Liver cancer is one of the most lethal cancers worldwide. Liquid biopsy provides a noninvasive approach in detecting and monitoring cancer biomarkers to overcome current limitations associated with tissue biopsies, comprising the analysis of circulating tumor-derived material. In this study, we profiled plasma cell-free RNA-seq to identify recurrently dysregulated RNA biomarkers for the liquid biopsy of cancer. SOURCE: Yumin Zhu (zhuym15@mails.tsinghua.edu.cn) -  Tsinghua University

Pluto Bioinformatics

GSE142987: RNA-seq analysis of liver cancer patients' plasma